Clinical trial NCT04717752 - References

Poor Ovarian Response — A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve

Citation(s)

•   Belova EV, Emtseva VP, Obolenskii IuA
  [Characteristics of autonomic and hormonal reactions during the performance of different types of intellectual work]. Fiziol Cheloveka. 1988 May-Jun;14(3):482-5. Russian.
•   Deepika K, Rathore S, Garg N, Rao K
  Empty follicle syndrome: Successful pregnancy following dual trigger. J Hum Reprod Sci. 2015 Jul-Sep;8(3):170-4. doi: 10.4103/0974-1208.165152.
•   Ding N, Liu X, Jian Q, Liang Z, Wang F
  Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2017 Nov;218:92-98. doi: 10.1016/j.ejogrb.2017.09.004. Epub 2017 Sep 14. Review.
•   Eftekhar M, Mojtahedi MF, Miraj S, Omid M
  Final follicular maturation by administration of GnRH agonist plus HCG versus HCG in normal responders in ART cycles: An RCT. Int J Reprod Biomed. 2017 Jul;15(7):429-434.
•   Eser A, Devranoglu B, Bostanci Ergen E, Yayla Abide Ç
  Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders. J Turk Ger Gynecol Assoc. 2018 Jun 4;19(2):98-103. doi: 10.4274/jtgga.2017.0045. Epub 2018 Mar 8.
•   Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition
  ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011 Jul;26(7):1616-24. doi: 10.1093/humrep/der092. Epub 2011 Apr 19.
•   Gold JI, Stocker AA
  Visual Decision-Making in an Uncertain and Dynamic World. Annu Rev Vis Sci. 2017 Sep 15;3:227-250. doi: 10.1146/annurev-vision-111815-114511. Epub 2017 Jul 17. Review.
•   Gonen Y, Balakier H, Powell W, Casper RF
  Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab. 1990 Oct;71(4):918-22.
•   Griesinger G, Diedrich K, Devroey P, Kolibianakis EM
  GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update. 2006 Mar-Apr;12(2):159-68. Epub 2005 Oct 27.
•   Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P
  Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril. 2007 Sep;88(3):616-21. Epub 2007 Apr 23.
•   Griesinger G, Meldrum D
  Introduction: Management of the luteal phase in assisted reproductive technology. Fertil Steril. 2018 May;109(5):747-748. doi: 10.1016/j.fertnstert.2018.02.009.
•   Griffin D, Benadiva C, Kummer N, Budinetz T, Nulsen J, Engmann L
  Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril. 2012 Jun;97(6):1316-20. doi: 10.1016/j.fertnstert.2012.03.015. Epub 2012 Apr 3.
•   Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C
  Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril. 2014 Aug;102(2):405-9. doi: 10.1016/j.fertnstert.2014.04.028. Epub 2014 May 17.
•   Lawrenz B, Coughlan C, Fatemi HM
  Individualized luteal phase support. Curr Opin Obstet Gynecol. 2019 Jun;31(3):177-182. doi: 10.1097/GCO.0000000000000530. Review.
•   Li S, Zhou D, Yin T, Xu W, Xie Q, Cheng D, Yang J
  Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols. Oncotarget. 2018 Jan 4;9(4):5337-5343. doi: 10.18632/oncotarget.23916. eCollection 2018 Jan 12.
•   Lin MH, Wu FS, Hwu YM, Lee RK, Li RS, Li SH
  Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve. Reprod Biol Endocrinol. 2019 Jan 4;17(1):7. doi: 10.1186/s12958-018-0451-x.
•   Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM
  Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril. 2013 Nov;100(5):1296-302. doi: 10.1016/j.fertnstert.2013.07.1976. Epub 2013 Aug 28.
•   Lu X, Hong Q, Sun L, Chen Q, Fu Y, Ai A, Lyu Q, Kuang Y
  Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist. Fertil Steril. 2016 Nov;106(6):1356-1362. doi: 10.1016/j.fertnstert.2016.07.1068. Epub 2016 Aug 1.
•   Nakano R, Mizuno T, Kotsuji F, Katayama K, Wshio M, Tojo S
  "Triggering" of ovulation after infusion of synthetic luteinizing hormone releasing factor (LRF). Acta Obstet Gynecol Scand. 1973;52(3):269-72.
•   Oliveira SA, Calsavara VF, Cortés GC
  Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual Trigger). JBRA Assist Reprod. 2016 Dec 1;20(4):246-250. doi: 10.5935/1518-0557.20160047. Review.
•   Orvieto R
  Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom? J Ovarian Res. 2015 Aug 21;8:60. doi: 10.1186/s13048-015-0187-6.
•   Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, Fischer R, Galliano D, Polyzos NP, Sunkara SK, Ubaldi FM, Humaidan P
  A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016 Jun;105(6):1452-3. doi: 10.1016/j.fertnstert.2016.02.005. Epub 2016 Feb 26.
•   Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A
  Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Fertil Steril. 2008 Oct;90(4):1087-93. Epub 2007 Nov 26.
•   Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M
  Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev. 2014 Oct 31;(10):CD008046. doi: 10.1002/14651858.CD008046.pub4. Review.
•   Zhou X, Guo P, Chen X, Ye D, Liu Y, Chen S
  Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders. Int J Gynaecol Obstet. 2018 Jun;141(3):327-331. doi: 10.1002/ijgo.12457. Epub 2018 Feb 21.
•   Zilberberg E, Haas J, Dar S, Kedem A, Machtinger R, Orvieto R
  Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes. Gynecol Endocrinol. 2015 Feb;31(2):145-7. doi: 10.3109/09513590.2014.978850. Epub 2014 Nov 11.

A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve

Details for clinical trial NCT04717752